Top compounds associated with response to RSPH9


Feature Type Standardized
Nominal ANOVA
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.089 0.006
mRNA nelarabine CTRPv2 pan-cancer AAC -0.1 0.007
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.008
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.088 0.009
mRNA simvastatin CTRPv2 pan-cancer AAC -0.1 0.009
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.01
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.076 0.01
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.01
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.01
mRNA R428 CTRPv2 pan-cancer AAC -0.11 0.01
Download CSV